Articles with "cancer mcrc" as a keyword



Photo by nci from unsplash

Durvalumab and tremelimumab in combination with FOLFOX in patients with RAS-mutated, microsatellite-stable, previously untreated metastatic colorectal cancer (MCRC): Results of the first intermediate analysis of the phase Ib/II MEDETREME trial.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.15_suppl.3006

Abstract: 3006Background: Single agent PD-1/L1 inhibition are not effective in metastatic colorectal cancer (MCRC) with microsatellite stable tumors. However, signal of efficacy was shown using combo therapy... read more here.

Keywords: cancer mcrc; metastatic colorectal; colorectal cancer; microsatellite stable ... See more keywords
Photo by nci from unsplash

BRCA mutations in metastatic colorectal cancer (mCRC) and response to chemotherapy.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.4_suppl.235

Abstract: 235Background: Mutations in BRCA 1/2 are typically associated with breast, ovarian, pancreatic and prostate cancers. BRCA mutations have been reported in colorectal cancer in sporadic case series. ... read more here.

Keywords: cancer mcrc; metastatic colorectal; mutations metastatic; colorectal cancer ... See more keywords
Photo from wikipedia

Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen

Sign Up to like & get
recommendations!
Published in 2022 at "PLoS ONE"

DOI: 10.1371/journal.pone.0269399

Abstract: Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line treatment. However, only 36% of the included patients were ≥65 years. Thus, we seek… read more here.

Keywords: patients years; cancer mcrc; metastatic colorectal; folfiri ... See more keywords
Photo by nci from unsplash

TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Molecular Sciences"

DOI: 10.3390/ijms232214436

Abstract: Colorectal cancer (CRC) is a serious public health issue, and it has the leading incidence and mortality among malignant tumors worldwide. CRC patients with metastasis in the liver, lung or other distant sites always have… read more here.

Keywords: cancer mcrc; metastatic colorectal; colorectal cancer; mcrc ... See more keywords